The outcomes of antiretroviral therapy, issues with drug induced adverse effects and the emergence of drug-resistant viruses could be improved with selective targeting of the CCR5 coreceptor subpopulations that are relevant for HIV-1 infection. The gene discussed is CCR5; the disease is HIV-1 infection.